RECO in the Endovascular Treatment of Acute Ischemic Stroke
RECO in the Endovascular Treatment of Acute Ischemic Stroke
Investigate Reco ® ,the first clot retriever in china as the primary therapyand remedies in
 the real world.
Endovascular thrombectomy (EVT) is effective and safe for acute ischemic stroke (AIS) caused
 by large vessel occlusion (LVO) in major clinical trials. Whether the benefit of EVT in
 randomized trials could be generalized to clinical practice, especially in developing
 countries, remains unknown. The Registry was established to evaluate the utilization, and
 subsequent outcomes of EVT treated AIS patients. This study is a multi-center, prospective
 registry study initiated by researchers, to investigate Reco ® ,the first clot retriever in
 china as the primary therapyand remedies in the real world.
Inclusion Criteria:

 1. Age ≥ 18 years old

 2. Diagnosis of acute ischemic stroke

 3. Imaging confirmed intracranial large artery occlusion (LVO): intracranial internal
 carotid artery (ICA T/L), middle cerebral artery (MCA M1/M2), anterior cerebral artery
 (ACA A1/A2), basilar artery (BA), vertebral artery (VA V4), and posterior cerebral
 artery (PCA P1);ASPECT or PC-ASPECT ≥ 6

 4. Initiation of any type of endovascular treatment (EVT), including intra-arterial
 thrombolysis, mechanical thrombectomy, angioplasty, and stenting

 5. The patient or the patient's legal representative is able and willing to sign the
 informed consent

 Exclusion Criteria:

 1. Isolated cervical ICA or VA occlusion;

 2. No evidence of LVO on DSA.